PATENT CLAIM ANALYSIS

Application Number: 15899061
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "210180"]

Abstract:
A compound of formula I, or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.

Claim (Index 17):
The method as claimed in  claim 16 , wherein the disease is selected from the group consisting of breast cancers, prostate cancers, lung cancers, oesophageal cancers, colon cancers, brain cancers, skin cancers, ovarian cancers, testicular cancers, neurofibromatosis and leukemias.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 88.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14647400', '15447818', '15315461', '15315478', '11123755']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8233555370344143
- 35 USC 102 Novelty (BERT): 0.5899432957438288
- Combined Prediction Score: 0.8000143129053559
- Mean Citation Score: 440.228286
- Max Citation Score: 523.1518
- Similarity Product: 415.6337490915536

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test